Navigation Links
CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine
Date:1/11/2010

ove patients' overall survival by 33% over what can be attained with standard treatment alone (without the addition of Multikine therapy) at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for this Phase III clinical trial and granted orphan drug status to Multikine in the neoadjuvant therapy of patients having squamous cell carcinoma (cancer) of the head and neck.

About Multikine

Multikine, a patented defined mixture of naturally derived cytokines, is the first immunotherapeutic agent in a new class of drugs called "Immune SIMULATORS". Immune SIMULATORS simulate the way our natural immune system acts in defending us against cancer. As opposed to other immunotherapies which are designed to target a single or limited number of specific antigens or molecules, Immune SIMULATORS are multi-targeted; they simultaneously cause a direct and targeted killing of the specific tumor cells and they activate the immune system to produce a stronger anti-tumor attack on multiple fronts.

Multikine is also the first immunotherapeutic agent being developed as a first-line standard of care treatment for cancer. It is administered prior to any other cancer therapy because that is the period when the anti-tumor immune response can still be fully activated. Once the patient has advanced disease, or had surgery or has received radiation and/or chemotherapy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered after the patient has received surgery, chemotherapy and/or radiation therapy, which can limit their effectiveness.

About CEL-SCI Corporation

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product Multikine is being readied for a global Phase III trial in advanced primary head and neck cancer. CEL-SCI is also devel
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI Hires Clinical Research Organization for Clinical Study With Hospitalized H1N1-Infected Patients
4. CEL-SCI Expands H1N1 Flu Virus Work
5. CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
6. CEL-SCI Posts New Corporate Presentation to Website
7. CEL-SCI Corporation Releases Letter to Shareholders
8. CEL-SCI Corporation Releases Letter to Shareholders
9. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
10. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015  Haemonetics Corporation (NYSE: HAE ) ... Officer, will present at the JMP Securities Life Sciences ... June 23 rd , 2015 at 11:30am Eastern time.  ... presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/29/2015)... , May 29, 2015 Amgen ... from two pivotal Phase 3, global, randomized, placebo-controlled ... the treatment of secondary hyperparathyroidism (SHPT) in patients ... studies met the primary endpoint, demonstrating that a ... groups achieved a greater than 30 percent reduction ...
(Date:5/28/2015)... Ind. , May 28, 2015 Zimmer ... that it has finalized agreements with buyers to divest ... Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow ... agreements are in furtherance of Zimmer,s pending acquisition of ... Zimmer continues to work constructively with the Bureau ...
Breaking Medicine Technology:Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6
(Date:5/29/2015)... 2015 World Patent Marketing, a vertically ... it has signed a 10 year licensing agreement for ... to let people learn about any topic and get ... "This is an exciting day for World Patent Marketing ... Cooper, CEO and Creative Director of World Patent Marketing, ...
(Date:5/29/2015)... 29, 2015 Inspire Nexus, a new ... solution to the question many life coaches have asked, ... experience and hours necessary to become a credentialed Coach?" ... question, but not for long. Inspire Nexus, a social ... Coaches directly. Coaches who have experience coaching a certain ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... to educate readers on the importance of proper sun ... within USA Today, with a circulation of approximately 250,000 ... digital component is distributed nationally, through a vast social ... sites and partner outlets. To explore the digital version ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... wellness, as well as a number of specific concerns ... care, stigma reduction and mental health in the workplace. ... about mental health. The campaign also brings special focus ... those individuals to speak up and seek help from ...
(Date:5/29/2015)... Shaila Jiwa, a physiotherapist from Burnaby ... stated in a new announcement that patients of urinary ... commonly seen as a tabooed topic to talk about ... like Shaila Jiwa try to encourage people to come ... is a condition that can be classified under two ...
Breaking Medicine News(10 mins):Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2
... 2008 Pet DRx,Corporation ("Pet DRx" or the "Company") (OTC ... services to companion,animals, today reported its financial results for the ... -- Revenues for the full year 2007 were $62.5 ... reported for the full year ended December 2006. The ...
... and Biosense Webster Executives Join Stereotaxis, ST. ... STXS ), announced today that it has made ... Company appointed Kevin Shifrin, most,recently the Vice President ... Division, as Stereotaxis, new Senior Vice President of,Global ...
... Mass., April 7, 2008 Biopure,Corporation (Nasdaq: ... a comment,letter from the United Kingdom,s Commission on ... for Hemopure(R),[hemoglobin glutamer - 250 (bovine)] pending with ... The comment letter states that the Commission was ...
... April 7 , - The Lancet Launches ... Health to Create an Archive of Science for ... April 7 sees the launch of a new, ... Health,Network http://www.thelancetglobalhealthnetwork.com ., The network will ...
... to big results when it comes to preventing childhood ... issue of Pediatrics. The school-based intervention, which reduced the ... means of preventing childhood weight gain and obesity on ... serious consequences of childhood obesity have pushed us to ...
... 7, 2008 News stories about an allegedly harmful ... the onset of autism had little effect on whether ... of immunization records and news stories. Parents decisions were ... the researchers said. , Researchers from The Children,s Hospital ...
Cached Medicine News:Health News:Pet DRx Corporation Reports 2007 Financial Results 2Health News:Pet DRx Corporation Reports 2007 Financial Results 3Health News:Pet DRx Corporation Reports 2007 Financial Results 4Health News:Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe 2Health News:Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe 3Health News:Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe 4Health News:Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R) 2Health News:Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R) 3Health News:Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R) 4Health News:The Lancet Global Health Network 2Health News:The Lancet Global Health Network 3Health News:The Lancet Global Health Network 4Health News:Changing school environment curbs weight gain in children 2Health News:Changing school environment curbs weight gain in children 3Health News:Parents follow pediatrician advice on administering MMR vaccinations 2Health News:Parents follow pediatrician advice on administering MMR vaccinations 3
... At the entry-level, Philips Zymed 1810 ... page preview, which gives the operator the ... or complex arrhythmia. Choose an application beyond ... more flexibility. Select the interactive or automatic ...
... EASITrak 12 gives you the detailed information ... decisions for your patients with palpitations, syncope ... the EASI Lead System, this transtelephonic cardiac ... capture a derived 12-lead ECG. Comfortable for ...
... This tiny, water-resistant monitor captures the ... and comfort. ,Requiring only five electrodes, ... recording for the entire patient test, which ... a single AA battery. Three channels of ...
... The biograph 6 offers the ... disease diagnosis and treatment in ... delivers high-quality PET/CT whole body ... minutes. Our comprehensive suite of ...
Medicine Products: